Loading clinical trials...
Loading clinical trials...
Italian Real-life Multicenter Observational Study on Efficacy, Tolerability, and Safety of Innovative Drugs (Monoclonal Antibodies, Gepants, Ditans, Sumatriptan-naproxen) for Preventive or Acute Migraine Treatment.
Conditions
Interventions
anti-CGRP monoclonal antibodies
gepants
+2 more
Locations
1
Italy
IRCCS San Raffaele
Rome, Italy, Italy
Start Date
March 24, 2022
Primary Completion Date
December 30, 2025
Completion Date
December 31, 2025
Last Updated
August 5, 2025
NCT06810505
NCT07071506
NCT07018713
NCT04715685
NCT05734625
NCT06248671
Lead Sponsor
IRCCS San Raffaele Roma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions